ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0062

Differential Metabolic Profiles, Activation and Circadian Dynamics in Rheumatoid Arthritis and Psoriatic Arthritis Circulatory Monocytes

Alyssa Gilmore1, Success Amaechi2, Megan Hanlon3, Dumitru Anton4, Carl Orr5, Viviana Marzaioli6, Douglas Veale7 and Ursula Fearon1, 1Trinity College Dublin, Dublin, Ireland, 2Trinity College Dublin, Mullingar, Ireland, 3Molecular Rheumatology, Dublin, Ireland, 4Molecular Rheumatology Department, Trinity Biomedical Sciences Institute, Trinity College Dublin, EULAR Centre for Arthritis and Rheumatic Diseases, St Vincent University Hospital, University College Dublin, Dublin, Ireland, 5Saint Vincent's University Hospital, Dublin, Ireland, 6Trinity College Dublin and University College Dublin, Dublin, Ireland, 7St.Vincent's University Hosp, Dublin, Ireland

Meeting: ACR Convergence 2023

Keywords: Mitochondrial Dysfunction, Monocytes/macrophages, Psoriatic arthritis, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0040–0064) Innate Immunity Poster

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: While Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA) share many features, they are distinct in clinical presentation and molecular profile. As monocytes are crucial innate effector cells, we investigate metabolic reprogramming of circulating monocytes in RA and PsA, and pathways involved in activation, circadian rhythm and mitochondrial dynamics.

Methods: PBMCs and CD14+ monocytes were isolated from RA and PsA patients. Frequency of monocyte subsets and immune/metabolism markers (PDL-1, HIF1a, pS6, TLR2 and pAKT) on specific subsets were assessed by flow cytometry. Metabolic analysis was performed on basal and LPS stimulated monocytes by RT-PCR, Seahorse-XFe-technology and mitotracker assays. In parallel, genes involved in circadian rhythm (BMAL1, PER1, PER2) and mitochondrial fission and fusion (DRP1, MFN1) and related effectors (RORα and NFIL3) were assessed by RT-PCR.

Results: Baseline ECAR following LPS stimulation was induced, with minimal effect observed for OCR, resulting in a significant shift of RA and PsA monocytes towards glycolysis (p< 0.05). A significant reduction in max respiratory capacity and ATP synthesis was also observed for PsA vs RA (all p< 0.05). Differential expression of PDL-1, pS6 and HIF1α were observed between RA and PsA monocytes, with inverse expression observed between classical and intermediate sub-populations. LPS modulated key metabolic genes HIF1α (p< 0.001) and NDufB5 (p< 0.05), an effect more prominent in RA monocytes. Supporting mitochondrial dysfunction in RA, LPS stimulation induced mitochondrial fission regulator DRP1 in RA (p< 0.0001), but not PsA. For circadian rhythm genes, LPS-stimulation inhibited BMAL1(p< 0.05) and PER1 (p< 0.001) in both RA and PsA, with reduction in PER2 only observed in PsA (p< 0.05). Finally, downstream effectors RORα and NFIL3 were increased with LPS in RA monocytes, with no effect observed for PsA.

Conclusion: RA and PsA CD14+ monocytes display a shift towards a glycolytic phenotype. Metabolic/immune markers are differentially expressed between RA and PsA monocytes, expression of which are inversed in classical vs intermediate monocytes. Altered regulation of genes involved in circadian rhythm suggest differences in the cellular clock, and effect that was more pronounced in RA compared to PsA monocytes. This was paralleled by altered mitochondrial dynamics, with significant induction of mitochondrial fission regulator DRP1 in RA monocytes. Taken together, this data, supports differential metabolic dysregulation and activation of RA and PsA monocytes, effects that may involve changes in the cellular clock, inducing monocyte pathogenic mechanisms.


Disclosures: A. Gilmore: None; S. Amaechi: None; M. Hanlon: None; D. Anton: None; C. Orr: None; V. Marzaioli: None; D. Veale: None; U. Fearon: None.

To cite this abstract in AMA style:

Gilmore A, Amaechi S, Hanlon M, Anton D, Orr C, Marzaioli V, Veale D, Fearon U. Differential Metabolic Profiles, Activation and Circadian Dynamics in Rheumatoid Arthritis and Psoriatic Arthritis Circulatory Monocytes [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/differential-metabolic-profiles-activation-and-circadian-dynamics-in-rheumatoid-arthritis-and-psoriatic-arthritis-circulatory-monocytes/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/differential-metabolic-profiles-activation-and-circadian-dynamics-in-rheumatoid-arthritis-and-psoriatic-arthritis-circulatory-monocytes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology